RELATED ARTICLES
Disrupting Alzheimer's Disease
Researchers, patient advocates and policymakers recently gathered in Chicago to discuss the unique c…
READ MOREPOPULAR ARTICLES
Can We Afford the New Era of Medicine?
Innovative treatments require innovative partnerships. America's Biopharmaceutical Companies and insurers are partnering to get the right medicine in the hands of patients who need them.
READ MORE
Researcher Profile: Victor Sloan
As vice president and development strategy lead at UCB, Victor Sloan has worked in the field of rheumatology since the early 1990's.
READ MORE
We Cannot Take Progress for Granted
We are in a new era of medical discovery and have the potential to revolutionize the treatment of costly and debilitating diseases. But we must not take this progress for granted.
READ MORE
The Greatest Gift of All: Hope
My son Parker's journey with juvenile arthritis (JA) began 10 years ago when he was in elementary school.
READ MORE
Migraine: More than Just a Bad Headache
Migraine is a debilitating neurological disease that is often misunderstood by those who do not suffer symptoms, according to the Migraine Impact Report, a new survey recently released by Eli Lilly and Company and conducted by Nielsen.
READ MORE
The Promise of Personalized Medicine
Discover how America's Biopharmaceutical Companies developed groundbreaking weapons to destroy the body's rogue cells.
READ MORE
Tackling Neurological Disorders in New Ways
Chronic pain. Alzheimer's disease. Multiple Sclerosis. Brain tumors. These are some of the most well-known and prevalent diseases afflicting the more than 100 million Americans who are impacted by a neurological disorder.
READ MORE